Related content

Neutralising antibodies to interferon β in multiple sclerosis: Expert panel report

By Hartung H.-P.   Polman C.   Bertolotto A.   Deisenhammer F.   Giovannoni G.   Havrdova E.   Hemmer B.   Hillert J.   Kappos L.   Kieseier B.   Killestein J.   Malcus C.   Comabella M.   Pachner A.   Schellekens H.   Sellebjerg F.   Selmaj K.   Sorensen P.  

Journal of Neurology, Vol. 254, Iss. 7, 2007-07 ,pp. : 827-837

Springer Publishing Company

Access to resources Recommend Favorite

Beta-interferon and multiple sclerosis

By Hall G.L.   Compston A.   Scolding N.J.  

Trends in Neurosciences, Vol. 20, Iss. 2, 1997-02 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite

A type I interferon signature in monocytes is associated with poor response to interferon- in multiple sclerosis

By Comabella M.   Lnemann J. D.   Ro J.   Snchez A.   Lpez C.   Juli E.   Fernndez M.   Nonell L.   Camia-Tato M.   Deisenhammer F.   Caballero E.   Tortola M. T.   Prinz M.   Montalban X.   Martin R.  

Brain, Vol. 132, Iss. 12, 2009-12 ,pp. : 3353-3365

Oxford University Press

Access to resources Recommend Favorite

JC virus viremia in interferon-β -treated and untreated Italian multiple sclerosis patients and healthy controls

By Delbue Serena   Guerini Franca Rosa   Mancuso Roberta   Caputo Domenico   Mazziotti Romina   Saresella Marina   Ferrante Pasquale  

Journal of NeuroVirology, Vol. 13, Iss. 1, 2007-01 ,pp. : 73-77

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Patient subgroup analyses of the treatment effect of subcutaneous interferon β-1a on development of multiple sclerosis in the randomized controlled REFLEX study

By Freedman Mark   Stefano Nicola   Barkhof Frederik   Polman Chris   Comi Giancarlo   Uitdehaag Bernard   Casset-Semanaz Florence   Hennessy Brian   Lehr Lorenz   Stubinski Bettina   Jack Dominic   Kappos Ludwig  

Journal of Neurology, Vol. 261, Iss. 3, 2014-03 ,pp. : 490-499

Springer Publishing Company

Access to resources Recommend Favorite